ATA532778A - Verfahren zur herstellung von neuen 19-norpregnahexaenderivaten - Google Patents

Verfahren zur herstellung von neuen 19-norpregnahexaenderivaten

Info

Publication number
ATA532778A
ATA532778A AT0532778A AT532778A ATA532778A AT A532778 A ATA532778 A AT A532778A AT 0532778 A AT0532778 A AT 0532778A AT 532778 A AT532778 A AT 532778A AT A532778 A ATA532778 A AT A532778A
Authority
AT
Austria
Prior art keywords
norpregnahexaen
derivatives
producing new
producing
new
Prior art date
Application number
AT0532778A
Other languages
English (en)
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of ATA532778A publication Critical patent/ATA532778A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT0532778A 1977-07-26 1978-07-21 Verfahren zur herstellung von neuen 19-norpregnahexaenderivaten ATA532778A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81918277A 1977-07-26 1977-07-26

Publications (1)

Publication Number Publication Date
ATA532778A true ATA532778A (de) 1982-12-15

Family

ID=25227423

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0532778A ATA532778A (de) 1977-07-26 1978-07-21 Verfahren zur herstellung von neuen 19-norpregnahexaenderivaten

Country Status (13)

Country Link
EP (1) EP0000609B1 (de)
JP (1) JPS5424864A (de)
AT (1) ATA532778A (de)
AU (1) AU518819B2 (de)
CA (1) CA1118410A (de)
DE (1) DE2861112D1 (de)
DK (1) DK326478A (de)
FI (1) FI782305A7 (de)
GR (1) GR73119B (de)
NO (1) NO782538L (de)
NZ (1) NZ187926A (de)
PT (1) PT68338A (de)
ZA (1) ZA784081B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897290A (en) * 1986-09-26 1990-01-30 Konishiroku Photo Industry Co., Ltd. Method for manufacturing the substrate for liquid crystal display

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3410879A (en) * 1967-04-12 1968-11-12 American Home Prod Process for preparing gonahexaenes

Also Published As

Publication number Publication date
JPS5424864A (en) 1979-02-24
EP0000609B1 (de) 1981-09-23
FI782305A7 (fi) 1979-01-27
CA1118410A (en) 1982-02-16
EP0000609A1 (de) 1979-02-07
PT68338A (en) 1978-08-01
AU518819B2 (en) 1981-10-22
DE2861112D1 (en) 1981-12-10
GR73119B (de) 1984-02-03
AU3824878A (en) 1980-01-24
NZ187926A (en) 1980-10-08
ZA784081B (en) 1979-07-25
DK326478A (da) 1979-01-27
NO782538L (no) 1979-01-29

Similar Documents

Publication Publication Date Title
AT367425B (de) Verfahren zur herstellung von neuen cephemderivaten
AT367426B (de) Verfahren zur herstellung von neuen cephemderivaten
AT362065B (de) Verfahren zur herstellung von neuen pleuromutilinglycosidderivaten
AT372093B (de) Verfahren zur herstellung von neuen corticoid-17- alkylcarbonaten
AT363182B (de) Verfahren zur herstellung von neuen cephemderivaten
AT371455B (de) Verfahren zur herstellung von neuen prostanderivaten
AT368753B (de) Verfahren zur herstellung von neuen azacycloalkanen
AT368137B (de) Verfahren zur herstellung von neuen 4-amino-5alkylthiopyrimidinen
AT357673B (de) Verfahren zur herstellung von neuen 9-amino- desoxyclavulansaeurederivaten
AT366368B (de) Verfahren zur herstellung von neuen chinolylguanidinen
LU78919A1 (de) Verfahren zur herstellung von neuen aminoalkoxyphenyl-derivaten
AT361622B (de) Verfahren zur herstellung von neuen anthra- cyclinglycosid-anitbiotika
AT365591B (de) Verfahren zur herstellung von neuen indolderivaten
ATA472577A (de) Verfahren zur herstellung von neuen 1-acyl-4- -hydroxy-imidazol-5-carboxamid-derivaten
AT362368B (de) Verfahren zur herstellung von neuen oxazolidin- 2-on-derivaten
AT372690B (de) Verfahren zur herstellung von neuen polyhydantoinen
AT360676B (de) Verfahren zur herstellung von neuen 17beta- -hydroxy-4-androsten-3-onen
AT371109B (de) Verfahren zur herstellung von neuen benzolsulfonamidderivaten
AT365203B (de) Verfahren zur herstellung von neuen 9-fluorprednisolon-derivaten
ATA750578A (de) Verfahren zur herstellung von neuen pyridothiazo- linen
AT371119B (de) Verfahren zur herstellung von neuen sulfoximid-derivaten
AT359517B (de) Verfahren zur herstellung von neuen alfa- -halogenaethylcarbamidsaeurehalogeniden
AT363473B (de) Verfahren zur herstellung von neuen 4-hydroxy-thiazolidin-2-thion-derivaten
AT365610B (de) Verfahren zur herstellung von neuen 19-nor-10cyano-peruvosid-derivaten
ATA532778A (de) Verfahren zur herstellung von neuen 19-norpregnahexaenderivaten

Legal Events

Date Code Title Description
A1J Withdrawal paragraph 166 lit. 6